Concord Wealth Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-279
Closed -$22K 1249
2022
Q1
$22K Buy
279
+68
+32% +$5.36K 0.01% 610
2021
Q4
$19K Buy
211
+160
+314% +$14.4K ﹤0.01% 653
2021
Q3
$4K Buy
51
+42
+467% +$3.29K ﹤0.01% 616
2021
Q2
$1K Hold
9
﹤0.01% 949
2021
Q1
$1K Buy
+9
New +$1K ﹤0.01% 887